mesalamine has been researched along with Cancer of Nasopharynx in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "An 80-year-old man with Crohn's disease treated with mesalazine presented with collapse and tonic-clonic seizure." | 1.46 | Delayed diagnosis of central skull-base osteomyelitis with abscess: case report and learning points. ( Chawdhary, G; Corbridge, R; Hussain, S, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chawdhary, G | 1 |
| Hussain, S | 1 |
| Corbridge, R | 1 |
1 other study available for mesalamine and Cancer of Nasopharynx
| Article | Year |
|---|---|
Delayed diagnosis of central skull-base osteomyelitis with abscess: case report and learning points.
Topics: Abscess; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Delayed Diagnosi | 2017 |